Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
the purpose of the study is to investigate the effect of blood flow restriction training on postmenopausal SUI.
We have two groups: control group (A) and experimental group (B) are two matched post-menopausal stress urinary incontinence. Group A will receive PFMT-associated EMG biofeedback, whereas Group B will receive PFMT-associated EMG biofeedback while applying blood flow restriction to the proximal thigh. Our primary outcome measures will be the severity of SUI symptoms, while the secondary outcome measures will involve QOL, self-esteem, patient's global impression of improvement, maximum voluntary isometric contraction (MVIC) of pelvic floor muscles, pelvic floor muscle resting tone, and the endurance of pelvic floor muscles,
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control group | Active Comparator | Control group will receive Pelvic floor muscle training-associated EMG biofeedback. |
|
| experimental group | Experimental | experimental group will receive Pelvic floor muscle training-associated EMG biofeedback while applying blood flow restriction to the proximal thigh. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| pelvic floor muscle training -associated EMG-biofeedback. | Other | The control group will receive pelvic floor muscle training-associated EMG biofeedback for 10 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| severity of stress urinary incontinence (SUI) symptoms. | severity of SUI symptoms, measured by the Arabic version of the International consultation on incontinence questionnaire-short form (ICIQ-UI SF) | baseline,10 weeks, 16 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of life (QOL) | QOL will be measured by International consultation on incontinence questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTS qol) | baseline,10 weeks, 16 weeks |
| self-esteem |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jilan Adel, lecturer | Contact | 01007519909 | +2 | gelan_youssif@pt.kfs.edu.eg |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000090003 | Blood Flow Restriction Therapy |
| ID | Term |
|---|---|
| D005081 | Exercise Therapy |
| D012046 | Rehabilitation |
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| blood flow restriction | Other | experimental group will receive Pelvic floor muscle training-associated EMG biofeedback while applying blood flow restriction to the proximal thigh for 10 weeks. |
|
self-esteem will be measured by Arabic Rosenberg self-esteem scale
| baseline,10 weeks, 16 weeks |
| patient's global impression of improvement | patient's global impression of improvement will be measured by Patient Global Impression of Improvement (PGI-I) scale. | baseline,10 weeks, 16 weeks |
| maximum voluntary isometric contraction (MVIC) of pelvic floor muscles | maximum voluntary isometric contraction (MVIC) of pelvic floor muscles will be measured by Neurotrac myoplus pro EMG | baseline,10 weeks, 16 weeks |
| pelvic floor muscle resting tone | pelvic floor muscle resting tone will be measured by Neurotrac myoplus pro EMG | baseline,10 weeks, 16 weeks |
| pelvic floor muscle endurance | pelvic floor muscle endurance will be measured by Neurotrac myoplus pro EMG | baseline,10 weeks, 16 weeks |
| D005791 |
| Patient Care |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |